Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CARMUSTINE | ACCORD HLTHCARE | N-215000 RX | 2022-05-16 | 2 products, RLD, RS |
BICNU | Avet Lifesciences | N-017422 RX | 1982-01-01 | 1 products, RLD, RS |
GLIADEL | Azurity | N-020637 RX | 1996-09-23 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
carmustine | ANDA | 2023-12-05 |
gliadel | New Drug Application | 2018-12-13 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
brain neoplasms | EFO_0003833 | D001932 | C71 |
carcinoma | — | D002277 | C80.0 |
colonic neoplasms | — | D003110 | C18 |
ependymoma | — | D004806 | — |
glioblastoma | EFO_0000515 | D005909 | — |
hodgkin disease | — | D006689 | C81 |
lung neoplasms | — | D008175 | C34.90 |
medulloblastoma | — | D008527 | — |
melanoma | — | D008545 | — |
multiple myeloma | — | D009101 | C90.0 |
Code | Description |
---|---|
J9050 | Injection, carmustine, 100 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 9 | 45 | 13 | — | 6 | 70 |
Central nervous system neoplasms | D016543 | — | — | 16 | 17 | 4 | — | — | 33 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 5 | 13 | 5 | — | 2 | 23 |
Glioblastoma | D005909 | EFO_0000515 | — | 6 | 14 | 5 | — | 2 | 22 |
Leukemia | D007938 | — | C95 | 2 | 9 | 2 | — | — | 13 |
Multiple myeloma | D009101 | — | C90.0 | 2 | 5 | 4 | — | 1 | 12 |
Follicular lymphoma | D008224 | — | C82 | 3 | 9 | 2 | — | 2 | 12 |
Plasma cell neoplasms | D054219 | — | — | 1 | 9 | 2 | — | 1 | 12 |
Glioma | D005910 | EFO_0000520 | — | 3 | 7 | 1 | — | 2 | 11 |
Neoplasms | D009369 | — | C80 | 3 | 4 | 1 | — | 1 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 12 | 20 | — | — | 2 | 26 |
Hodgkin disease | D006689 | — | C81 | 6 | 12 | — | — | 3 | 17 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 6 | 11 | — | — | 2 | 14 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | 6 | — | — | 1 | 8 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 5 | — | — | 2 | 7 |
T-cell lymphoma peripheral | D016411 | — | — | — | 3 | — | — | 2 | 5 |
Gliosarcoma | D018316 | — | — | 1 | 4 | — | — | — | 4 |
Burkitt lymphoma | D002051 | — | C83.7 | 2 | 1 | — | — | 2 | 4 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 1 | 1 | — | — | 2 | 4 |
B-cell lymphoma | D016393 | — | — | 2 | 2 | — | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroblastoma | D009447 | EFO_0000621 | — | 1 | — | — | — | 1 | 2 |
Nausea | D009325 | HP_0002018 | R11.0 | 1 | — | — | — | — | 1 |
Pancreatic ductal carcinoma | D021441 | — | — | 1 | — | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | 1 | — | — | — | — | 1 |
Adenocarcinoma | D000230 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Extranodal nk-t-cell lymphoma | D054391 | — | C86.0 | — | — | — | — | 2 | 2 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | — | — | — | — | 2 | 2 |
Intraocular lymphoma | D064090 | — | — | — | — | — | — | 2 | 2 |
Large-cell lymphoma immunoblastic | D016400 | — | — | — | — | — | — | 2 | 2 |
Lymphomatoid granulomatosis | D008230 | — | C83.8 | — | — | — | — | 2 | 2 |
Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | — | — | — | — | 1 | 1 |
Hairy cell leukemia | D007943 | — | C91.4 | — | — | — | — | 1 | 1 |
Large granular lymphocytic leukemia | D054066 | — | — | — | — | — | — | 1 | 1 |
Retinoblastoma | D012175 | — | — | — | — | — | — | 1 | 1 |
Immunoglobulin light-chain amyloidosis | D000075363 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Carmustine |
INN | carmustine |
Description | Carmustine is a member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group. It has a role as an alkylating agent and an antineoplastic agent. It is a member of N-nitrosoureas and an organochlorine compound. |
Classification | Small molecule |
Drug class | antineoplastics (chloroethylamine derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=NN(CCCl)C(=O)NCCCl |
PDB | — |
CAS-ID | 154-93-8 |
RxCUI | — |
ChEMBL ID | CHEMBL513 |
ChEBI ID | 3423 |
PubChem CID | 2578 |
DrugBank | DB00262 |
UNII ID | U68WG3173Y (ChemIDplus, GSRS) |